CoreAge Rx vs NewSelf
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and NewSelf head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
NewSelf
FDA warning letter, February 2026 — issued to NewSelf Limited dba NewSelf. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 78 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make NewSelf a bad call — it's best for readers who can obtain a written three-month quote and understand the cancellation fees before choosing an installment option. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | NewSelf |
|---|---|---|
| Brief Score | 94/100 (A) | 78/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm current price Earlier listing: From $100/mo (compounded) (checked July 2026). Confirm the medication, billing term and full charge before paying. Full price detailsCompounded semaglutide offered. Current medication quote unknown; earlier listing: From $100/mo (compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm current price Earlier listing: From $144/mo (compounded) (checked July 2026). Confirm the medication, billing term and full charge before paying. Full price detailsCompounded tirzepatide offered. Current medication quote unknown; earlier listing: From $144/mo (compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | 49 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
NewSelf: Earlier prices remain historical. Current pages show conflicting medication quotes; obtain the full three-month charge, installment schedule and applicable early cancellation fee before paying.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.